Ila Singh, MD, PhD

Dr. Singh serves as Chief of Laboratory Medicine, and Chief of Pathology Informatics at Texas Children’s Hospital, and as tenured Professor of Pathology & Immunology at Baylor College of Medicine. She is the Program Director for the Clinical Informatics fellowship. Dr. Singh completed her M.D. at the University of Bombay, and her Ph.D. at Yale University. She served as a Jane Coffin Childs Fellow at Stanford University and completed her Clinical Pathology residency training at Columbia University Medical Center in New York City.

She is dual board-certified in Clinical Pathology and in Clinical Informatics. She is interested in testing and reporting for COVID-19, and the impact of the pandemic on laboratory testing in general. Dr. Singh has special expertise in Laboratory Test Utilization Management/Stewardship, as evidenced by her involvement in creating the first Clinical and Laboratory Standards Institute (CLSI) document on Test

Utilization, and her membership on the national committee on Lab Test Utilization and Stewardship that co-authored the consensus document on the subject. Her current research is focused on using Artificial Intelligence/Deep Learning approaches to determine risk stratification, prescriptive analytics, better utilization of healthcare resources, and optimization of treatment protocols. She is the founder of TRUU-Lab, a national initiative to change the names of clinical lab tests to those that are more standardized and easily understood by clinicians.